⌘K

Login Start Free

Home/Filings/4/0001144204-16-078612

4//SEC Filing

IMMUNE PHARMACEUTICALS INC 4

Accession 0001144204-16-078612

CIK 0001208261operating

View on SEC.gov Company Profile

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 9:24 PM ET

Size

5.5 KB

Accession

0001144204-16-078612

Insider Transaction Report

Form 4

Period: 2016-01-29

IMMUNE PHARMACEUTICALS INCIMNP

Director

Transactions

Award
Stock Option
2016-01-29+40,000→ 40,000 total
Exercise: $0.53From: 2016-01-29Exp: 2026-01-29→ Common Stock (40,000 underlying)

Footnotes (1)

[F1]The stock options shall vest in equal quarterly installments over a one-year period.

Documents

1 file

4
v430443_form4.xmlPrimary
FORM 4

Issuer

IMMUNE PHARMACEUTICALS INC

CIK 0001208261

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001208261

Filing Metadata

Form type: 4
Filed: Feb 1, 7:00 PM ET
Accepted: Feb 2, 9:24 PM ET
Size: 5.5 KB

View on SEC.gov